Title: | A Pure Herbal Prophylactic Contraceptive for HIV Infection |
Area: | Traditional Knowledge, Medical Sciences |
Focus Area: | Prevention of HIV Infection |
Patent: | US8729034, ZA200908410 |
Social Benefits: | Ac-B has an anti-HIV property and capable to prevent HIV infection at a dose level of greater than or equal to 1.0 microgram per ml in vitro, which is perhaps well within tolerable limits ( Hemolytic index: 7 microgram per ml). MEC of Ac-B is 125micro g/ml for spermicidal activity on human sperm which is significantly lower than that of closest prior arts (MEC for N-9:200-500 microgram/ml through vaginal route. Significant spermicidal as well as virucidal activities with apparently no possible mutagenic effects and adverse effects on vaginal ecology. Ac-B is non-mutagenic as tested in Ames Test. Ac-B does not interfere with the growth of Lactobacillus acidophilus in laboratory culture, at least up to a concentration of 500 mg/ml. Thus it application does not lead to an increased risk of opportunistic infections. Its molecular size is about three fold higher than N-9, which makes it likely to be absorbed weekly through vaginal route. |
Developing Agency: | CSIR-Indian Institute of Chemical Biology (IICB), West Bengal |
Technology Readiness Index: | Lab Validation |
Email: | director@iicb.res.in |
| Website Link : | http://www.iicb.res.in |
| Source (more info) : | https://t.ly/l_sb |